Ultragenyx Pharmaceutical
RARE
#3251
Rank
โ‚น299.25 B
Marketcap
โ‚น3,097
Share price
-4.26%
Change (1 day)
-20.92%
Change (1 year)

Ultragenyx Pharmaceutical (RARE) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : โ‚น106.13 Billion

According to Ultragenyx Pharmaceutical's latest financial reports the company's total liabilities are โ‚น106.13 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Ultragenyx Pharmaceutical - Total liabilities on balance sheet (from 2012 to 2024)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚น106.47 B5.22%
2023-12-31โ‚น101.19 B2.51%
2022-12-31โ‚น98.71 B121.11%
2021-12-31โ‚น44.64 B0.88%
2020-12-31โ‚น44.25 B28.84%
2019-12-31โ‚น34.35 B344.01%
2018-12-31โ‚น7.73 B12.93%
2017-12-31โ‚น6.85 B51.26%
2016-12-31โ‚น4.52 B139.32%
2015-12-31โ‚น1.89 B129.32%
2014-12-31โ‚น0.82 B40.03%
2013-12-31โ‚น0.58 B170.73%
2012-12-31โ‚น0.21 B176.94%
2011-12-31โ‚น78.6 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚น113.81 B 7.23%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น50.53 B-52.38%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น62.64 B-40.98%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น13.03 B-87.72%๐Ÿ‡บ๐Ÿ‡ธ USA